Standard BioTools Inc. develops and manufactures life science research tools based on mass cytometry and microfluidics technologies. Its CyTOF and Hyperion platforms enable high-parameter single-cell analysis and spatial tissue imaging for proteomics and genomics applications. The company supplies these systems, assays and services to researchers seeking detailed biological insights in translational and clinical settings.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 21.8 | — | -33.5 | — |
| Q3 2025 | 19.6 | — | -34.7 | — |
| Q4 2025 | 23.8 | — | 19.3 | — |
| Q1 2026 | 21.1 | — | 127.1 | — |
| Q2 2026 | 20.1 | -7.6% | -26.8 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Super League Enterprise, Inc. (SLE), Inflection Point Acquisition Corp. VIII (IPHX), Richmond Mutual Bancorporation, Inc. (RMBI), Palisade Bio, Inc. (PALI), Quantum-Si incorporated (QSI), Swarmer, Inc (SWMR)